Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • VERICHEM LABORATORIES EXPANDS REPORT OPTIONS FOR ITS FREE CLIA COMPLIANT CALIBRATION VERIFICATION PROGRAM

    Feb 15, 2021, 12:30 PM by
    VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.
    Full story
  • Scytek Laboratories Inc Stain Nuclei Histology Red Special Stain,Histology,Nuclear Fast Red Solution,H E,Eosin

    Feb 15, 2021, 12:30 PM by
    Scytek laboratories offers special Stain, Antibodies, Hematology, Microbiology, Hematoxlyn, Nuclei Histology Red Special Stain, Histology ,Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek
    Full story
  • eClinical Solutions Launches elluminate® Clinical Trial Management System (CTMS) for Faster Drug Development

    Feb 15, 2021, 12:30 PM by
    This announcement is in response to the growing need in the industry for solutions like elluminate CTMS that can automate operational data pipelines and reduce the time spent on manual data tracking processes to accelerate clinical development. ​ ​
    Full story
  • Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen

    Feb 15, 2021, 12:30 PM by
    Full story
  • Kyruus Announces Significant Core Business Momentum in 2020 as it Accelerates Expansion into the Health Plan Market with Recent Acquisition

    Feb 15, 2021, 12:30 PM by
    Full story
  • THREAD and 1nHealth Partner to Optimize Participant Recruitment in Decentralized Clinical Trials

    Feb 15, 2021, 12:30 PM by
    Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials
    Full story
  • IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange (DLX™) platform with Polar™, IDBS’ Biopharmaceutical Lifecycle Management (BPLM) platform

    Feb 15, 2021, 12:30 PM by
    Full story
  • Dotmatics collaborates with HighRes Biosolutions to provide single software interface for lab digitalization

    Feb 15, 2021, 12:30 PM by
    Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN
    Full story
  • BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research

    Feb 15, 2021, 12:30 PM by
    The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.
    Full story
  • Antibiotic Research UK calls for clear guidance to ensure people on antibiotics do not miss out on the COVID-19 vaccine

    Feb 15, 2021, 12:30 PM by
    Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination.
    Full story
  • Hallmarks of a Super-Spreader, Spike Pattern of the 1928 Pandemic, Airborne Transmission Model: COVID-19 Updates

    Feb 12, 2021, 01:00 AM by User Not Found
    Bio-IT World | New machine learning framework estimates asymptomatic cases, helium microscope used to visualize SARS CoV-2, SARS CoV-2 mutations develop in single patient, and new vaccine platforms. Plus: clinicians at UCI Health develop successful system for monoclonal antibody delivery, New Yorkers are responding more favorably to the new COVID-19 vaccine, and old drugs may be repurposed as COVID-19 treatments.
    Full story
  • A Deep Dive On mRNA Vaccines

    Feb 11, 2021, 01:00 AM by User Not Found
    Bio-IT World | Messenger RNA (mRNA) vaccines were the focus of a symposium on COVID-19 vaccines held during last week’s COVID-19 and Cancer virtual meeting of the American Association for Cancer Research. To date, only two vaccines have received Emergency Use Authorization by the U.S. Food and Drug Administration and both are mRNA vaccines—one developed by Moderna and the other by Pfizer and BioNTech.
    Full story
  • Sema4 Announces Merger With CM Life Sciences

    Feb 10, 2021, 18:53 PM by User Not Found
    Bio-IT World | Sema4 announced its planned merger with CM Life Sciences today. The transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP. The transaction is expected to provide up to $793 million in immediate cash proceeds.
    Full story
  • The Future of Our Blood Supply Chain is Digital

    Feb 10, 2021, 01:00 AM by User Not Found
    Bio-IT World | The impact of the COVID-19 pandemic on our nation’s blood supply was not very apparent in public discussion. And yet the radical shifts in the demand for blood products, and the availability thereof, should be studied and analyzed to improve the robustness and resilience of our blood supply.
    Full story
  • GenomePaint: Interactive Visualization of the Genome

    Feb 9, 2021, 01:00 AM by User Not Found
    Bio-IT World | The computational biology team at St. Jude has published the latest on GenomePaint, one of the visualization features in the St. Jude Cloud platform, in the January issue of Cancer Cell.
    Full story
  • Heparin Inhibits SARS-CoV-2, How Mutations Escape Immune Response, Retraining Generic Antibodies: COVID-19 Updates

    Feb 5, 2021, 01:00 AM by User Not Found
    Bio-IT World | Genetic sequence deletions help SARS-CoV-2 escape antibodies, molecular behavior of COVID-19 drugs, and the latest COVID-19 forecasts include two new variants. Plus: N439K variant shows two-fold increase in binding affinity and heparin inhibits SARS-CoV-2 spike protein, could be repurposed.
    Full story
  • AI-Based Approach Crunches Real-World Data To Emulate Clinical Trials

    Feb 4, 2021, 01:00 AM by User Not Found
    Bio-IT World | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing.
    Full story
  • Is Precision Medicine Ready For Data From Billions Of Cells?

    Feb 3, 2021, 01:00 AM by User Not Found
    Bio-IT World | Popular opinion is that two big shifts have changed the game for bioinformatics. The first is single cell ‘omics, the other is a more recent move to a new model of drug discovery that looks to leverage the vast amounts of human genetic data now being generated in support of precision medicine. But to achieve datasets with the 100,000s of patients and treatment conditions that are needed for statistical power in pharma R&D and precision medicine, IT tools to manage billions of cells are essential.
    Full story
  • Intel, Google Donate Compute Credits, Cloud Space To All Of Us Program

    Feb 2, 2021, 18:31 PM by User Not Found
    Bio-IT World | Intel and Google have joined the National Institutes of Health (NIH) All of Us Research Program in its historic effort to improve population health by making biomedical data from underrepresented groups available to COVID-19 researchers nationwide via the Researcher Workbench.
    Full story
  • H3Africa Consortium Primes A Continent For Large-Scale Genomics Research

    Feb 2, 2021, 01:00 AM by User Not Found
    Bio-IT World | Only a fraction of the genetic diversity among African individuals had previously been surveyed—even by large-scale efforts such as the 1000 Genomes Project. That’s why H3Africa’s sequencing is so important. A study published last year in Nature found evidence for natural selection in and around 62 previously unreported genes.
    Full story
  • «
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy